Home Page : www.otcjournal.com
Email Questions or Comments To:
editor@otcjournal.com
To
OTC Journal Members:
 |
Comments
in the BLOG |
 |
There was a new BLOG entry
on Family Room Entertainment this past week. In case you didn't
catch it, FMLY signed on to produce the "King of California" starring
Oscar Winner Michael Douglas. The film is slated to go into
production in February of '06. Between the reincarnation of Rambo with
Stallone, and the Michael Douglas picture, FMLY already has two
films in the can for 2006. 88 Minutes with Pacino should come next year
as well. They're are off to a good start as far as matching their 8 picture
performance in '05. Please visit the BLOG to read my comments on
the new film and more importantly the stock of the stock price.
To use the BLOG, simply go
to the home page at www.otcjournal.com
- the BLOG will scroll down automatically on the right side of your
screen. The most current journal entries appear in the middle of your screen.
Check back frequently for updates particularly when stocks are moving to
overbought or oversold levels or in volatile markets. Your questions and
postings do not automatically appear, so don't bother posting the same
question multiple times. I personally go through to moderate and respond
to every question.
|
Coming
Attractions: Crude Down; Stocks Up |
|
The market should take a short term
breather before resuming what is setting up to be a strong 4th quarter
rally. As I write today's edition, crude prices have dropped below the
highly watched technical support level of $58- Currently $57.75. No doubt,
there is an inevitable bounce coming, but oil continues making a series
of lower highs and lower lows. The breaching of the $58 level brings $52
into the cross hairs. If we head below $55, it will be time to look at
energy stocks once again, as I am convinced the long term supply/demand
dynamic could lead to much higher levels. At $55 to $56, I will publish
an edition with some ideas in long term dividend paying energy stocks.
In the interim, I am going to be
introducing several new ideas in the microcap arena over the next month.
Despite the rebound in the broader market, the micros have yet to participate.
Retail investors remain sidelined during 2005- the year of "Energy
Shock". Interest rates are slowing headed north, and the media
is very busy predicting a correction in home values. It's not a great environment
to get excited about small stocks.
This is exactly why I'm excited right
now. Volumes and values are the lowest they have been for some time. It's
a great environment to do some bargain basement shopping.
Do you remember September? We were
hit with the perfect two storms, our energy infrastructure got walloped,
and oil hit $70 per barrel. CNBC, the ultimate crowd follower, provided
me with endless entertainment as they trotted out every "expert" on the
planet willing to predict oil at $110 per barrel.
That may well come to pass, but not
right away. Not without a cooling down and a correction.
The pendulum will swing back to micros,
and when it does I want you to be positioned. I still love biotech as the
next big thing. With KAL we have a cancer related idea. Type II
Diabetes treatments is another target as the disease has now reached epidemic
proportions in the US.
I have two new ideas to share for
potential breakthroughs in diabetes. In all, the OTC Journal will
end up with three ideas in the Diabetes market. I am already covering one-
Health
Sciences Group, which has a nice breakthrough today, is a diabetes
idea with a natural product. There are two more to come in the medical
device industry- the riskier and earlier stage to come this weekend, and
the less risky later stage sometime in the next two weeks.
Also, I'm working on a telecom company
with a $20 million market valuation, significant growth, $30 million in
annual sales, and profitable. There is 100% upside in this one. Look for
the first coverage the middle of next week if it all checks out.
 |
SHUGR To Make
Debut on QVC |
|
The short term future of HESG
is tied to their ability to get SHUGR into the market place. The
product is gaining traction in the retail environment, having found its
way onto the shelves at GNC, The Vitamin Shoppe, and a host of drug stores
nationwide.
Their next potential blockbuster
product, Sequestrol, will be sold by infomercial, which is going
into production right now.
SHUGR will start to sell in
larger quantities once the company starts supporting sales at the retail
level with point-of-purchase display and advertising. A plan is underway
for this support.
As the company gears up to enhance
sales at the retail level, it is also working on a number of other avenues
to get the product to market. Currently, there are a number of food manufacturers
testing SHUGR as an ingredient for their products. These include
both baked goods and beverages.
Today after the market closed, HESG
announced SHUGR will become a featured product on the venerable
QVC network. QVC reaches 87 million homes in the US, and enjoys $5.7 billion
in annual sales.
The product will be introduced by
QVC preferred seller Lori Greiner's For Your Ease Only company. In all,
since 1966, Greiner's company has introduced 60 successful products on
QVC.
The offer is expected to begin airing
in January, and is expected to include a ½ lb. baker's bag of Shugr
specially designed for QVC, 25 single-serving packets of Shugr,
two dozen chocolate chip cookies baked with Shugr and a recipe book
containing ideas for baking with Shugr. The bundled package
is expected to sell for $22.85.
Technically, the chart of HESG
is about as bullish as it gets. There might even be a "trampoline" trade
in this stock if you can pick it up in the $.60 range.
The stock has just completed the
bullish "double repo" of the DiNapoli 3x3 displaced moving average. In
English, the stock broke above the 3x3 and broke back below within 8 trading
sessions. If you recall, we showed you the exact opposite of the chart
when oil starting selling off. It predicted the commodity sell off very
accurately, and this indicator will probably predict the upside move in
HESG
as well.
Longer term, SHUGR simply
needs to get in front of more consumers. QVC is one big step in
that direction. There are many more to come. This situation is going to
get very exciting between now and the end of the year.
Here is the complete text of today's
news for your review:
| Press Release Source:
Health Sciences Group, Inc.
Health Sciences Group,
Inc. Enters Agreement with Regular Host to Sell Shugr on QVC
Thursday November 10,
4:26 pm ET
LOS ANGELES--(BUSINESS
WIRE)--Nov. 10, 2005--Health Sciences Group, Inc. (OTCBB:HESG - News),
provider of innovative nutraceutical products and functional food ingredients
derived from natural sources, announced today that it has entered into
an agreement with Lori Greiner and her company, For Your Ease Only, Inc.,
a QVC "preferred seller", to sell Shugr Natural Sweetener on QVC. The promotional
segment is expected to air in January 2006.
"We are very excited
about the prospects of working with Lori and selling Shugr on QVC," said
Fred E. Tannous, co-Chairman and Chief Executive Officer of Health Sciences
Group, Inc. "With a reach into 87 million homes, QVC offers us a fantastic
opportunity to sell Shugr to millions of consumers while also increasing
awareness across various other retail channels. We expect this relationship
will help boost Shugr sales across the board."
The promotional offering
is expected to include a baker's bag of Shugr specially designed for QVC
customers, 25 single-serving packets of Shugr, two dozen chocolate chip
cookies baked with Shugr and recipes for baking with Shugr. The retail
price for the bundled package is expected to range between $20.00 and $24.00.
While the company has
an agreement with Lori Greiner and For Your Ease Only, the final product
offering, configuration and pricing are subject to final approval by the
management of QVC.
Shugr Natural Sweetener,
the first zero-calorie, low glycemic sweetener that tastes and measures
like table sugar, is made from sugars that occur naturally in such good-tasting,
healthy foods such as fruits, vegetables, corn and dairy products. Erythritol
is a naturally-occurring sugar commonly found in melon, grapes, mushrooms
and soy. Tagatose comes from dairy products, but does not affect people
who are lactose intolerant. Tagatose also provides an added health benefit
-- prebiotic fiber that promotes intestinal health, much the way yogurt
does. Maltodextrin is derived from corn sugar, which is non-GMO and gluten-free.
A trace amount of sucralose is added to give Shugr its "high note." All
of these ingredients carry a GRAS (Generally Recognized As Safe) designation
for food safety from the US Food & Drug Administration.
About For Your Ease Only,
Inc.
Since 1996 Lori Greiner
and her company, For Your Ease Only, Inc. has featured over 60 clever and
unique products and are constantly developing and promoting new and innovative
products every day. Lori leads the management team, working closely with
companies in the USA and abroad, to ensure the highest level of quality
control.
About QVC, Inc.
QVC, Inc., a $5.7 billion
company, is an e-commerce leader, marketing a wide variety of brand name
products in such categories as home furnishings, licensed products, fashion,
beauty, electronics and fine jewelry. QVC reaches over 87 million homes
in the United States. Other divisions/subsidiaries include QVC.com, Q Direct,
Q Records and Video, QVC @, QVC Local, QVC ProductWorks. The QVC Studio
Tour is located at the company's world headquarters in West Chester, PA.
About Health Sciences
Group, Inc.
Health Sciences Group
identifies, develops and commercializes innovative nutraceutical products
derived from natural sources to provide consumers and medical professionals
with preventative healthcare alternatives. The company markets its own
line of proprietary products based on novel technologies with clinically-supported,
GRAS-certified ingredients under its Swiss Research(TM) and Swiss Diet(TM)
brand names. For more information, visit www.HSciences.com and www.Shugr.com.
This release contains
forward-looking statements within the meaning of Section 27A of the Securities
Act of 1933 and Section 21E of the Securities Act of 1934 that are based
upon current expectations or beliefs, as well as a number of assumptions
about future events. Although the Company believes that the expectations
reflected in the forward-looking statements and the assumptions upon which
they are based are reasonable, it can give no assurance that such expectations
and assumptions will prove to have been correct. The reader is cautioned
not to put undue reliance on these forward-looking statements, as these
statements are subject to numerous factors and uncertainties, including
without limitation, the independent authority of the special committee
to act on the matters discussed, the successful negotiation of the potential
acquisition and disposal of transactions described above, successful implementation
of the company's business strategy and competition, any of which may cause
actual results to differ materially from those described in the statements.
In addition, other factors that could cause actual results to differ materially
are discussed in the Company's most recent Form 10-QSB and Form 10-KSB
filings with the Securities and Exchange Commission.
Contact:
Health Sciences Group,
Inc.
Duke Best, 310-242-6700
Source: Health Sciences
Group, Inc.
|
|
Subscribe |
|
Information is power and timely information is profitable. Become informed and profit from OTC Journal Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription.
Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the OTC Journal Email Newsletter on a regular basis.
To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best
way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable
email newsletter delivery.
Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition.
|
